We are innovators, explorers, and dreamers who have created the ROSALIND Platform to reinvent and transform the genomic analysis experience so that we all may realize the benefits of Precision Medicine. Rather than trying to cure cancer ourselves, we’re passionately building the best platform so that our customers can.
ROSALIND helps the world’s leading life science researchers to derive more value from their data and complete projects faster. We believe the potential of biomedical and multi-omic data is maximized when it is accessible, interactive, and shareable. Extracting meaningful insights from pools of data takes a truly interoperable ecosystem that breaks down silos of complex information and sparks collaboration.
Serving as Vice President at Hewlett-Packard, Tim led strategy & partnerships with the market leaders like FaceBook, MapR, Cloudera, and DataStax with solutions that companies like Apple, Amazon, Microsoft, Baidu, and many others heavily rely on today. He saw the opportunity to bring this knowledge of advanced computing technology into the healthcare space and founded ROSALIND to empower researchers, doctors, and drug developers to accelerate genomic discoveries through collaboration so that we all can realize the promise of precision medicine and unlock biology's greatest unknowns.
Jean joined ROSALIND after more than 25 years experience in Genomics, Bioinformatics, and Information Technology at Illumina and UCSD. He uniquely brings deep experience and knowledge of biology, wet lab operations, microarrays, and next-generation sequencing together with advanced bioinformatics, software development, and enterprise IT infrastructure with a Masters in Computer Science from Institut national des Sciences appliquées de Toulouse / INSA Toulouse, and a B.S. Computer Science from IUT de Clermont-Ferrand - Université d'Auvergne
Jeremy earned his Ph.D. in Bioinformatics and Systems Biology in the lab of Alexander Hoffmann at UCSD, researching kinetic models of co-transcriptional splicing. He also brings extensive experience in microarrays, weighted gene coexpression network analysis, pathways analyses, gene set enrichment, and motif analysis. His ambitious goal of enabling researchers without programming experience to ask quantitative questions led to the development of web portals featuring tools to query relational databases of expression data (microarray and sequencing) and perform on-the-fly computational analyses.
We named our solution in honor of the pioneering researcher Rosalind Franklin, Ph.D. who made a major contribution to the discovery of the double-helix structure of DNA with her famous Photograph 51. The ROSALIND® platform aims to bring better collaboration and data science to genomic data interpretation so that organizations and institutes can harness the potential of high-value data from DNA sequencing to microarrays and mass spec, while reducing costs and increasing productivity.
Our company values focus on compassion, integrity, and collaboration, and we are proud to be a founding member of The Rosalind Franklin Society Council of Corporate Leadership.
